Pyronaridine

Pyronaridine
Systematic (IUPAC) name
4-[(7-Chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol
Clinical data
Routes of
administration
Oral, intramuscular injection, intravenous therapy
Legal status
  • CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413)
Identifiers
CAS Number 74847-35-1 N
ATC code none
PubChem CID 5485198
ChemSpider 10647812 YesY
UNII TD3P7Q3SG6 YesY
ChEMBL CHEMBL35228 YesY
Chemical data
Formula C29H32ClN5O2
Molar mass 518.05 g/mol
 NYesY (what is this?)  (verify)

Pyronaridine is an antimalarial drug. It was first synthesized in 1970 and has been in clinical use in China since the 1980s.[1]

It is one of the components of the artemisinin combination therapy pyronaridine artesunate (Pyramax).

References

  1. Chang C, Lin-Hua T, Jantanavivat C (1992). "Studies on a new antimalarial compound: pyronaridine". Trans R Soc Trop Med Hyg 86 (1): 7–10. doi:10.1016/0035-9203(92)90414-8. PMID 1566313.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.